JPMorgan Chase & Co’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-65
| Closed | -$19 | – | 6790 |
|
|
2025
Q1 | $19 | Sell |
65
-4
| -6% | -$1 | ﹤0.01% | 6258 |
|
|
2024
Q4 | $29 | Sell |
69
-2
| -3% | -$1 | ﹤0.01% | 6169 |
|
|
2024
Q3 | $33 | Sell |
71
-1
| -1% | – | ﹤0.01% | 6113 |
|
|
2024
Q2 | $38 | Buy |
72
+61
| +555% | +$32 | ﹤0.01% | 6047 |
|
|
2024
Q1 | $9 | Hold |
11
| – | – | ﹤0.01% | 6230 |
|
|
2023
Q4 | $32 | Hold |
11
| – | – | ﹤0.01% | 6231 |
|
|
2023
Q3 | $25 | Sell |
11
-23,549
| -100% | -$53.5K | ﹤0.01% | 6167 |
|
|
2023
Q2 | $50.7K | Sell |
23,560
-34,619
| -60% | -$74.4K | ﹤0.01% | 4859 |
|
|
2023
Q1 | $129K | Buy |
58,179
+58,168
| +528,800% | +$129K | ﹤0.01% | 4547 |
|
|
2022
Q4 | $0 | Hold |
11
| – | – | ﹤0.01% | 5997 |
|
|
2022
Q3 | $0 | Hold |
11
| – | – | ﹤0.01% | 5879 |
|
|
2022
Q2 | $0 | Sell |
11
-113,370
| -100% | – | ﹤0.01% | 5958 |
|
|
2022
Q1 | $227K | Sell |
113,381
-4,986
| -4% | -$9.98K | ﹤0.01% | 4382 |
|
|
2021
Q4 | $528K | Sell |
118,367
-7,092
| -6% | -$31.6K | ﹤0.01% | 4028 |
|
|
2021
Q3 | $754K | Sell |
125,459
-38,398
| -23% | -$231K | ﹤0.01% | 3757 |
|
|
2021
Q2 | $1.84M | Sell |
163,857
-16,166
| -9% | -$181K | ﹤0.01% | 3269 |
|
|
2021
Q1 | $2.99M | Sell |
180,023
-8,804
| -5% | -$146K | ﹤0.01% | 2989 |
|
|
2020
Q4 | $4.59M | Buy |
+188,827
| New | +$4.59M | ﹤0.01% | 2487 |
|